Controlling normothermia in perioperative patients can be almost as important to their health as the surgical procedure itself. Research is revealing more and more the negative implications of even small dips in patient temperature.

Induced hypothermia has traditionally been used perioperatively as a strategy for neurological protection during major vascular surgery or for situations where neurological injury is present or imminent. However, patients cannot deviate off of the normal core body temperature of around 37°C for long without risk of deleterious effects.

In the years since 9/11, disaster medicine has come into its own. Now a recognized specialty, the practice of disaster preparedness, disaster planning, disaster response and disaster recovery as it relates to the practice of medicine and the function of healthcare and healthcare institutions has moved from the realm of the emergency manager and hospital safety officer into the realm of the healthcare professional.

August 20, 2007 - Cardiatis, SA announced that it has completed recruitment of patients into its first European clinical trial of its 3D Multilayer Braided Stent for repairing aneurysms.

August 15, 2007 - Performing cardiac CTA after coronary artery bypass surgery (CABG) can reveal unsuspected and potentially significant findings beyond the heart, according to a recent study conducted by researchers at the University of Maryland School of Medicine, located in Baltimore, MD.

August 15, 2007 - Thoratec Corp., a world leader in products to treat cardiovascular disease, said today that its PMA (PreMarket Application) seeking approval of its HeartMate II for bridge-to-transplantation will undergo review by an FDA advisory panel later this year.

August 15, 2007 - InspireMD announced today receipt of orders for its MGuard Coronary stents from key markets in Western Europe and Latin America, after results from clinical trials in Germany showed a procedural success rate of 100 percent.

August 15, 2007 - Merit Medical Systems Inc., a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology procedures, announced today that it has acquired the exclusive distribution rights for microcatheters from GMA Co., Ltd. with the rights over all North American, South American and European markets, as well as Middle Eastern and Asian markets.

August 14, 2007 — ProSolv CardioVascular, a FUJIFILM company, announced today that it is the newest MedAxiom corporate partner, a resource for cardiology practices with a network of 250 plus cardiology groups representing over 5500 physicians, in a deal that will make ProSolv CardioVascular the first cardiovascular image and information system (CVIIS) company to join the MedAxiom group.

August 15, 2007 — ProSolv CardioVascular, a FUJIFILM company, announced that it is the newest MedAxiom Corporate Partner.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now